Age-related macular degeneration. (Photo credit: Community Eye Health)
Scientists at Trinity College, Dublin say they have made a major breakthrough in treatment for age-related macular degeneration (AMD) – the leading cause of blindness in people over 50.
Through their research, they have discovered that interleukin-18 (IL-18), a component of the immune system, can protect patients from vision loss, and it can be administered in a non-invasive way. Since current treatments for AMD involve periodically injecting medication directly into the eyeball, this could have significant implications for AMD therapy.
“[IL-18] has already entered into clinical trials [for cancer research], and it has a very good safety profile when administered intravenously. It was never injected into the eye,” study author Matthew Campbell, research assistant professor in genetics at Trinity, told FoxNews.com.
“So all the signs show this could be another tool in the arsenal against wet AMD.”
AMD has two major forms: “dry,” the more common form, and “wet,” which accounts for 90 percent of the severe vision loss caused by macular degeneration. When a patient suffers from wet AMD, the blood vessels grow into the retina, the layer of tissue lining the inner surface of the eye, and begin to leak blood or fluid – causing immediate retinal blindness. Retinal blindness can be especially challenging for patients, as the retina provides sharp, central vision for reading, driving and perceiving small details.
In order to combat wet AMD, patients m? patients must receive them on a monthly basis.
Campbell and his team say IL-18 can work just as effectively as these anti-VEGF injections, as it produces cells that prevent wet AMD.
The Latest on: Age-related macular degeneration
via Google News
The Latest on: Age-related macular degeneration
- Thousands to get new treatment on NHS for wet age-related macular degenerationon May 27, 2022 at 5:30 am
Thousands of people in England will be able to get new treatment on the NHS for wet age-related macular degeneration or for diabetic macular oedema.
- Age-Related Macular Degenerationon May 24, 2022 at 4:59 pm
Various screening tests may be used by an ophthalmologist to establish a diagnosis. These include visual acuity tests, dilated funduscopic examination, optical coherence tomography, fluorescein ...
- Age-Related Macular Degenerationon May 22, 2022 at 5:00 pm
Age-related macular degeneration (ARMD) is the most common cause of severe vision loss in elderly persons in developed countries and accounts for one-third of cases of untreatable vision loss.
- Complement C3 Variant and the Risk of Age-Related Macular Degenerationon May 18, 2022 at 5:01 pm
Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation ...
- How Doctors Diagnose Wet Age-Related Macular Degeneration (Wet AMD)on May 17, 2022 at 5:00 pm
If you’re having vision problems or have been diagnosed with dry age-related macular degeneration (AMD), your doctor may recommend testing to see if you have the wet form of AMD. Your macula is ...
- Age-Related Macular Degeneration Market Size, Opportunities, Trends, Products, Revenue Analysis Till 2027on May 17, 2022 at 5:49 am
The age-related macular degeneration market is soaring higher all across the globe in recent times. So, the market value is predicted to reach USD 11.18 billion during the forecast period. Over the ...
- Age-Related Macular Degenerationon May 17, 2022 at 1:27 am
Paulus T.V.M. de Jong, M.D., Ph.D. Figure 2. Figure 2. Progression from Early to Late Age-Related Macular Degeneration. Figure 3. Figure 3. RPE Cell in a 3-Year-Old Child (Left-Hand Panel ...
- Wet Age-Related Macular Degeneration Market to flourish with a 4.5% CAGR and has a Promising Outlook with Emerging Therapies, Estimates DelveInsighton May 16, 2022 at 4:00 pm
Market” report provides a thorough comprehension of the Wet Age-Related Macular Degeneration, historical and forecasted epidemiology, and the wet AMD market trends in the 7MM [the United States, EU5 ...
- Age-Related Macular Degeneration Treatment Market Is Predicted To Witness Healthy Growthon May 16, 2022 at 12:49 am
Age-Related Macular Degeneration Treatment Market NEW YORK, NY, U.S., May 15, 2022 /EINPresswire.com / -- A report was released recently ...
- Age Related Macular Degeneration Drug Market Size, Share, Statistics, Demand and Revenue, Forecast 2025on May 2, 2022 at 7:05 am
May 02, 2022 (Market Insight Reports) -- Global Age Related Macular Degeneration Drug Market Report focuses on the major drivers and restraints for the key players. These Research Report also ...
via Bing News
